These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31653462)

  • 21. Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: Findings from the UMPIRE multi-center study.
    Tanaka ST; Yerkes EB; Routh JC; Tu DD; Austin JC; Wiener JS; Vasquez E; Joseph DB; Ahn JJ; Wallis MC; Williams T; Rose C; Baum MA; Cheng EY
    J Pediatr Urol; 2021 Oct; 17(5):726-732. PubMed ID: 34011486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty].
    Marte A; Vessella A; Cautiero P; Romano M; Borrelli M; Noviello C; Del Gado R; Parmeggiani P
    Minerva Pediatr; 2005 Feb; 57(1):35-40. PubMed ID: 15791200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of risk of anticholinergic utilization for treatment of neurogenic bladder between in utero or postnatal myelomeningocele repair.
    Zaccaria L; Daugherty M; Grant C; Strine AC; Reddy PP; DeFoor WR; Minevich E; Lim FY; VanderBrink BA
    J Pediatr Urol; 2021 Aug; 17(4):525.e1-525.e7. PubMed ID: 34074608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How early is early? Effect of oxybutynin on bladder dynamics within the first year of life in patients with spina bifida.
    Lee AS; Viseshsindh W; Long CJ; Frazier JR; Moran MH; Zderic SA; Weiss DA
    J Pediatr Urol; 2020 Apr; 16(2):168.e1-168.e6. PubMed ID: 32115375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and urodynamic findings in children and adolescents with neurogenic bladder undergoing augmentation cystoplasty: a systematic review.
    Reis OAF; Ito HN; de Oliveira Otávio J; de Oliveira Filho DJ; Lima EM; de Bessa J; da Silva PLL; de Almeida Vasconcelos MM; de Carvalho Mrad FC
    Pediatr Nephrol; 2024 Sep; ():. PubMed ID: 39249128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropathic Bladder and Augmentation Cystoplasty.
    Roth JD; Cain MP
    Urol Clin North Am; 2018 Nov; 45(4):571-585. PubMed ID: 30316312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia.
    Şekerci ÇA; Işbilen B; Işman F; Akbal C; Şimşek F; Tarcan T
    J Urol; 2014 Jan; 191(1):199-205. PubMed ID: 23973519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk determination for upper urinary tract damage in children with neuropathic bladder.
    Ekberlİ G; Taner S
    J Paediatr Child Health; 2023 Jul; 59(7):863-870. PubMed ID: 36999336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup.
    Hopps CV; Kropp KA
    J Urol; 2003 Jan; 169(1):305-8. PubMed ID: 12478177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of videourodynamic study in the decision-making of surgical intervention and bladder management for neurogenic lower urinary tract dysfunction among patients with myelomeningocele.
    Yu WR; Kuo HC
    Int Urol Nephrol; 2022 Aug; 54(8):1815-1824. PubMed ID: 35608803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bladder perforation in augmentation cystoplasty during urodynamic investigation: a case report and review of the literature.
    Ehdaie B; Mason MD; Gray M; Peters CA; Corbett ST
    J Pediatr Urol; 2013 Apr; 9(2):e102-6. PubMed ID: 23238439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term results of augmentation cystoplasty and urinary diversion in multiple sclerosis.
    Kalkan S; Jaffe WI; Simma-Chiang V; Li ESW; Blaivas JG
    Can J Urol; 2019 Jun; 26(3):9774-9780. PubMed ID: 31180308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of upper tract damage in pediatric neurogenic bladder.
    Prakash R; Puri A; Anand R; Jain AK; Lal B; Garg V
    J Pediatr Urol; 2017 Oct; 13(5):503.e1-503.e7. PubMed ID: 28385450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ureteral reimplantation during augmentation cystoplasty is not needed for vesicoureteral reflux in patients with neurogenic bladder: a long-term retrospective study.
    Chiba H; Kitta T; Higuchi M; Kusakabe N; Kon M; Nakamura M; Shinohara N
    BMC Urol; 2022 Mar; 22(1):48. PubMed ID: 35351067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does surgical release of secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele?
    Tarcan T; Onol FF; Ilker Y; Simsek F; Ozek M
    J Urol; 2006 Oct; 176(4 Pt 1):1601-6; discussion 1606. PubMed ID: 16952698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upper tract changes in patients with neurogenic bladder and sustained pressures >40 cm following bladder neck surgery without augmentation.
    Snodgrass W; Villaneuva C; Jacobs M; Gargollo P
    J Pediatr Urol; 2014 Aug; 10(4):744-8. PubMed ID: 24566376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.
    Hascoet J; Peyronnet B; Forin V; Baron M; Capon G; Prudhomme T; Allenet C; Tournier S; Maurin C; Cornu JN; Bouali O; Peycelon M; Arnaud A; Renaux-Petel M; Liard A; Karsenty G; Manunta A; Game X
    Urology; 2018 Jun; 116():161-167. PubMed ID: 29522865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial urologic management of myelomeningocele.
    Snodgrass WT; Adams R
    Urol Clin North Am; 2004 Aug; 31(3):427-34, viii. PubMed ID: 15313052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of Bacteriuria in Myelomeningocele Patients at Time of Urodynamic Testing.
    Preece J; Haynes A; Gupta S; Becknell B; Ching C
    Top Spinal Cord Inj Rehabil; 2019; 25(3):241-247. PubMed ID: 31548791
    [No Abstract]   [Full Text] [Related]  

  • 40. Onabotulinumtoxin A for treating overactive/poor compliant bladders in children and adolescents with neurogenic bladder secondary to myelomeningocele.
    Marte A
    Toxins (Basel); 2012 Dec; 5(1):16-24. PubMed ID: 23274271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.